{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.666.5.2349","meta":{"versionId":"12","lastUpdated":"2016-03-31T01:00:12.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2349","version":"20160331","name":"Immunocompromised Therapies I10","status":"active","date":"2016-03-31T01:00:12-04:00","publisher":"Lantana EH Steward","compose":{"include":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","concept":[{"code":"3E00X05","display":"Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach"},{"code":"3E00X0M","display":"Introduction of Monoclonal Antibody into Skin and Mucous Membranes, External Approach"},{"code":"3E01305","display":"Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach"},{"code":"3E0130M","display":"Introduction of Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach"},{"code":"3E02305","display":"Introduction of Other Antineoplastic into Muscle, Percutaneous Approach"},{"code":"3E0230M","display":"Introduction of Monoclonal Antibody into Muscle, Percutaneous Approach"},{"code":"3E03002","display":"Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach"},{"code":"3E03003","display":"Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach"},{"code":"3E03005","display":"Introduction of Other Antineoplastic into Peripheral Vein, Open Approach"},{"code":"3E0300M","display":"Introduction of Monoclonal Antibody into Peripheral Vein, Open Approach"},{"code":"3E0300P","display":"Introduction of Clofarabine into Peripheral Vein, Open Approach"},{"code":"3E03302","display":"Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach"},{"code":"3E03303","display":"Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach"},{"code":"3E03305","display":"Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach"},{"code":"3E0330M","display":"Introduction of Monoclonal Antibody into Peripheral Vein, Percutaneous Approach"},{"code":"3E0330P","display":"Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach"},{"code":"3E04002","display":"Introduction of High-dose Interleukin-2 into Central Vein, Open Approach"},{"code":"3E04003","display":"Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach"},{"code":"3E04005","display":"Introduction of Other Antineoplastic into Central Vein, Open Approach"},{"code":"3E0400M","display":"Introduction of Monoclonal Antibody into Central Vein, Open Approach"},{"code":"3E0400P","display":"Introduction of Clofarabine into Central Vein, Open Approach"},{"code":"3E04302","display":"Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach"},{"code":"3E04303","display":"Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach"},{"code":"3E04305","display":"Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach"},{"code":"3E0430M","display":"Introduction of Monoclonal Antibody into Central Vein, Percutaneous Approach"},{"code":"3E0430P","display":"Introduction of Clofarabine into Central Vein, Percutaneous Approach"},{"code":"3E05002","display":"Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach"},{"code":"3E05003","display":"Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach"},{"code":"3E05005","display":"Introduction of Other Antineoplastic into Peripheral Artery, Open Approach"},{"code":"3E0500M","display":"Introduction of Monoclonal Antibody into Peripheral Artery, Open Approach"},{"code":"3E0500P","display":"Introduction of Clofarabine into Peripheral Artery, Open Approach"},{"code":"3E05302","display":"Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach"},{"code":"3E05303","display":"Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach"},{"code":"3E05305","display":"Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach"},{"code":"3E0530M","display":"Introduction of Monoclonal Antibody into Peripheral Artery, Percutaneous Approach"},{"code":"3E0530P","display":"Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach"},{"code":"3E06002","display":"Introduction of High-dose Interleukin-2 into Central Artery, Open Approach"},{"code":"3E06003","display":"Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach"},{"code":"3E06005","display":"Introduction of Other Antineoplastic into Central Artery, Open Approach"},{"code":"3E0600M","display":"Introduction of Monoclonal Antibody into Central Artery, Open Approach"},{"code":"3E0600P","display":"Introduction of Clofarabine into Central Artery, Open Approach"},{"code":"3E06302","display":"Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach"},{"code":"3E06303","display":"Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach"},{"code":"3E06305","display":"Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach"},{"code":"3E0630M","display":"Introduction of Monoclonal Antibody into Central Artery, Percutaneous Approach"},{"code":"3E0630P","display":"Introduction of Clofarabine into Central Artery, Percutaneous Approach"},{"code":"3E09305","display":"Introduction of Other Antineoplastic into Nose, Percutaneous Approach"},{"code":"3E0930M","display":"Introduction of Monoclonal Antibody into Nose, Percutaneous Approach"},{"code":"3E09705","display":"Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening"},{"code":"3E0970M","display":"Introduction of Monoclonal Antibody into Nose, Via Natural or Artificial Opening"},{"code":"3E09X05","display":"Introduction of Other Antineoplastic into Nose, External Approach"},{"code":"3E09X0M","display":"Introduction of Monoclonal Antibody into Nose, External Approach"},{"code":"3E0A305","display":"Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach"},{"code":"3E0A30M","display":"Introduction of Monoclonal Antibody into Bone Marrow, Percutaneous Approach"},{"code":"3E0B305","display":"Introduction of Other Antineoplastic into Ear, Percutaneous Approach"},{"code":"3E0B30M","display":"Introduction of Monoclonal Antibody into Ear, Percutaneous Approach"},{"code":"3E0B705","display":"Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening"},{"code":"3E0B70M","display":"Introduction of Monoclonal Antibody into Ear, Via Natural or Artificial Opening"},{"code":"3E0BX05","display":"Introduction of Other Antineoplastic into Ear, External Approach"},{"code":"3E0BX0M","display":"Introduction of Monoclonal Antibody into Ear, External Approach"},{"code":"3E0C305","display":"Introduction of Other Antineoplastic into Eye, Percutaneous Approach"},{"code":"3E0C30M","display":"Introduction of Monoclonal Antibody into Eye, Percutaneous Approach"},{"code":"3E0C705","display":"Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening"},{"code":"3E0C70M","display":"Introduction of Monoclonal Antibody into Eye, Via Natural or Artificial Opening"},{"code":"3E0CX05","display":"Introduction of Other Antineoplastic into Eye, External Approach"},{"code":"3E0CX0M","display":"Introduction of Monoclonal Antibody into Eye, External Approach"},{"code":"3E0D305","display":"Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach"},{"code":"3E0D30M","display":"Introduction of Monoclonal Antibody into Mouth and Pharynx, Percutaneous Approach"},{"code":"3E0D705","display":"Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening"},{"code":"3E0D70M","display":"Introduction of Monoclonal Antibody into Mouth and Pharynx, Via Natural or Artificial Opening"},{"code":"3E0DX05","display":"Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach"},{"code":"3E0DX0M","display":"Introduction of Monoclonal Antibody into Mouth and Pharynx, External Approach"},{"code":"3E0E305","display":"Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach"},{"code":"3E0E30M","display":"Introduction of Monoclonal Antibody into Products of Conception, Percutaneous Approach"},{"code":"3E0E705","display":"Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening"},{"code":"3E0E70M","display":"Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening"},{"code":"3E0E805","display":"Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0E80M","display":"Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0F305","display":"Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach"},{"code":"3E0F30M","display":"Introduction of Monoclonal Antibody into Respiratory Tract, Percutaneous Approach"},{"code":"3E0F705","display":"Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening"},{"code":"3E0F70M","display":"Introduction of Monoclonal Antibody into Respiratory Tract, Via Natural or Artificial Opening"},{"code":"3E0F805","display":"Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0F80M","display":"Introduction of Monoclonal Antibody into Respiratory Tract, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0G305","display":"Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach"},{"code":"3E0G30M","display":"Introduction of Monoclonal Antibody into Upper GI, Percutaneous Approach"},{"code":"3E0G705","display":"Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening"},{"code":"3E0G70M","display":"Introduction of Monoclonal Antibody into Upper GI, Via Natural or Artificial Opening"},{"code":"3E0G805","display":"Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0G80M","display":"Introduction of Monoclonal Antibody into Upper GI, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0H305","display":"Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach"},{"code":"3E0H30M","display":"Introduction of Monoclonal Antibody into Lower GI, Percutaneous Approach"},{"code":"3E0H705","display":"Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening"},{"code":"3E0H70M","display":"Introduction of Monoclonal Antibody into Lower GI, Via Natural or Artificial Opening"},{"code":"3E0H805","display":"Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0H80M","display":"Introduction of Monoclonal Antibody into Lower GI, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0J305","display":"Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach"},{"code":"3E0J30M","display":"Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Percutaneous Approach"},{"code":"3E0J705","display":"Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening"},{"code":"3E0J70M","display":"Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Via Natural or Artificial Opening"},{"code":"3E0J805","display":"Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0J80M","display":"Introduction of Monoclonal Antibody into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0K305","display":"Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach"},{"code":"3E0K30M","display":"Introduction of Monoclonal Antibody into Genitourinary Tract, Percutaneous Approach"},{"code":"3E0K705","display":"Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening"},{"code":"3E0K70M","display":"Introduction of Monoclonal Antibody into Genitourinary Tract, Via Natural or Artificial Opening"},{"code":"3E0K805","display":"Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0K80M","display":"Introduction of Monoclonal Antibody into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0L305","display":"Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach"},{"code":"3E0L30M","display":"Introduction of Monoclonal Antibody into Pleural Cavity, Percutaneous Approach"},{"code":"3E0L705","display":"Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening"},{"code":"3E0L70M","display":"Introduction of Monoclonal Antibody into Pleural Cavity, Via Natural or Artificial Opening"},{"code":"3E0M305","display":"Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach"},{"code":"3E0M30M","display":"Introduction of Monoclonal Antibody into Peritoneal Cavity, Percutaneous Approach"},{"code":"3E0M705","display":"Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening"},{"code":"3E0M70M","display":"Introduction of Monoclonal Antibody into Peritoneal Cavity, Via Natural or Artificial Opening"},{"code":"3E0N305","display":"Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach"},{"code":"3E0N30M","display":"Introduction of Monoclonal Antibody into Male Reproductive, Percutaneous Approach"},{"code":"3E0N705","display":"Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening"},{"code":"3E0N70M","display":"Introduction of Monoclonal Antibody into Male Reproductive, Via Natural or Artificial Opening"},{"code":"3E0N805","display":"Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0N80M","display":"Introduction of Monoclonal Antibody into Male Reproductive, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0P305","display":"Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach"},{"code":"3E0P30M","display":"Introduction of Monoclonal Antibody into Female Reproductive, Percutaneous Approach"},{"code":"3E0P705","display":"Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening"},{"code":"3E0P70M","display":"Introduction of Monoclonal Antibody into Female Reproductive, Via Natural or Artificial Opening"},{"code":"3E0P805","display":"Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0P80M","display":"Introduction of Monoclonal Antibody into Female Reproductive, Via Natural or Artificial Opening Endoscopic"},{"code":"3E0Q305","display":"Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach"},{"code":"3E0Q30M","display":"Introduction of Monoclonal Antibody into Cranial Cavity and Brain, Percutaneous Approach"},{"code":"3E0Q705","display":"Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening"},{"code":"3E0Q70M","display":"Introduction of Monoclonal Antibody into Cranial Cavity and Brain, Via Natural or Artificial Opening"},{"code":"3E0R302","display":"Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach"},{"code":"3E0R303","display":"Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach"},{"code":"3E0R305","display":"Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach"},{"code":"3E0R30M","display":"Introduction of Monoclonal Antibody into Spinal Canal, Percutaneous Approach"},{"code":"3E0S302","display":"Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach"},{"code":"3E0S303","display":"Introduction of Low-dose Interleukin-2 into Epidural Space, Percutaneous Approach"},{"code":"3E0S305","display":"Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach"},{"code":"3E0S30M","display":"Introduction of Monoclonal Antibody into Epidural Space, Percutaneous Approach"},{"code":"3E0U305","display":"Introduction of Other Antineoplastic into Joints, Percutaneous Approach"},{"code":"3E0U30M","display":"Introduction of Monoclonal Antibody into Joints, Percutaneous Approach"},{"code":"3E0V305","display":"Introduction of Other Antineoplastic into Bones, Percutaneous Approach"},{"code":"3E0V30M","display":"Introduction of Monoclonal Antibody into Bones, Percutaneous Approach"},{"code":"3E0W305","display":"Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach"},{"code":"3E0W30M","display":"Introduction of Monoclonal Antibody into Lymphatics, Percutaneous Approach"},{"code":"3E0Y305","display":"Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach"},{"code":"3E0Y30M","display":"Introduction of Monoclonal Antibody into Pericardial Cavity, Percutaneous Approach"},{"code":"3E0Y705","display":"Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening"},{"code":"3E0Y70M","display":"Introduction of Monoclonal Antibody into Pericardial Cavity, Via Natural or Artificial Opening"}]}]},"expansion":{"identifier":"urn:uuid:3581e9c8-dbe6-4781-811a-c81ae393202b","timestamp":"2022-06-10T08:40:08-04:00","total":150,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E00X05","display":"Introduction of Other Antineoplastic into Skin and Mucous Membranes, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E00X0M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Skin and Mucous Membranes, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E01305","display":"Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0130M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E02305","display":"Introduction of Other Antineoplastic into Muscle, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0230M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Muscle, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E03002","display":"Introduction of High-dose Interleukin-2 into Peripheral Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E03003","display":"Introduction of Low-dose Interleukin-2 into Peripheral Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E03005","display":"Introduction of Other Antineoplastic into Peripheral Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0300M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0300P","display":"Introduction of Clofarabine into Peripheral Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E03302","display":"Introduction of High-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E03303","display":"Introduction of Low-dose Interleukin-2 into Peripheral Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E03305","display":"Introduction of Other Antineoplastic into Peripheral Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0330M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0330P","display":"Introduction of Clofarabine into Peripheral Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E04002","display":"Introduction of High-dose Interleukin-2 into Central Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E04003","display":"Introduction of Low-dose Interleukin-2 into Central Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E04005","display":"Introduction of Other Antineoplastic into Central Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0400M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0400P","display":"Introduction of Clofarabine into Central Vein, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E04302","display":"Introduction of High-dose Interleukin-2 into Central Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E04303","display":"Introduction of Low-dose Interleukin-2 into Central Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E04305","display":"Introduction of Other Antineoplastic into Central Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0430M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Central Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0430P","display":"Introduction of Clofarabine into Central Vein, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E05002","display":"Introduction of High-dose Interleukin-2 into Peripheral Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E05003","display":"Introduction of Low-dose Interleukin-2 into Peripheral Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E05005","display":"Introduction of Other Antineoplastic into Peripheral Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0500M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0500P","display":"Introduction of Clofarabine into Peripheral Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E05302","display":"Introduction of High-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E05303","display":"Introduction of Low-dose Interleukin-2 into Peripheral Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E05305","display":"Introduction of Other Antineoplastic into Peripheral Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0530M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Peripheral Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0530P","display":"Introduction of Clofarabine into Peripheral Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E06002","display":"Introduction of High-dose Interleukin-2 into Central Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E06003","display":"Introduction of Low-dose Interleukin-2 into Central Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E06005","display":"Introduction of Other Antineoplastic into Central Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0600M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0600P","display":"Introduction of Clofarabine into Central Artery, Open Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E06302","display":"Introduction of High-dose Interleukin-2 into Central Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E06303","display":"Introduction of Low-dose Interleukin-2 into Central Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E06305","display":"Introduction of Other Antineoplastic into Central Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0630M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Central Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0630P","display":"Introduction of Clofarabine into Central Artery, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E09305","display":"Introduction of Other Antineoplastic into Nose, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0930M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E09705","display":"Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0970M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Nose, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E09X05","display":"Introduction of Other Antineoplastic into Nose, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E09X0M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Nose, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0A305","display":"Introduction of Other Antineoplastic into Bone Marrow, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0A30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Bone Marrow, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0B305","display":"Introduction of Other Antineoplastic into Ear, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0B30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0B705","display":"Introduction of Other Antineoplastic into Ear, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0B70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Ear, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0BX05","display":"Introduction of Other Antineoplastic into Ear, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0BX0M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Ear, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0C305","display":"Introduction of Other Antineoplastic into Eye, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0C30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0C705","display":"Introduction of Other Antineoplastic into Eye, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0C70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Eye, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0CX05","display":"Introduction of Other Antineoplastic into Eye, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0CX0M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Eye, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0D305","display":"Introduction of Other Antineoplastic into Mouth and Pharynx, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0D30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0D705","display":"Introduction of Other Antineoplastic into Mouth and Pharynx, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0D70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0DX05","display":"Introduction of Other Antineoplastic into Mouth and Pharynx, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0DX0M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Mouth and Pharynx, External Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0E305","display":"Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0E30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0E705","display":"Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0E70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0E805","display":"Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0E80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Products of Conception, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0F305","display":"Introduction of Other Antineoplastic into Respiratory Tract, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0F30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0F705","display":"Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0F70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0F805","display":"Introduction of Other Antineoplastic into Respiratory Tract, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0F80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Respiratory Tract, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0G305","display":"Introduction of Other Antineoplastic into Upper GI, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0G30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0G705","display":"Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0G70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0G805","display":"Introduction of Other Antineoplastic into Upper GI, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0G80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Upper GI, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0H305","display":"Introduction of Other Antineoplastic into Lower GI, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0H30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0H705","display":"Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0H70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0H805","display":"Introduction of Other Antineoplastic into Lower GI, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0H80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Lower GI, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0J305","display":"Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0J30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0J705","display":"Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0J70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0J805","display":"Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0J80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0K305","display":"Introduction of Other Antineoplastic into Genitourinary Tract, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0K30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0K705","display":"Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0K70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0K805","display":"Introduction of Other Antineoplastic into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0K80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Genitourinary Tract, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0L305","display":"Introduction of Other Antineoplastic into Pleural Cavity, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0L30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0L705","display":"Introduction of Other Antineoplastic into Pleural Cavity, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0L70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Pleural Cavity, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0M305","display":"Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0M30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0M705","display":"Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0M70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0N305","display":"Introduction of Other Antineoplastic into Male Reproductive, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0N30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0N705","display":"Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0N70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0N805","display":"Introduction of Other Antineoplastic into Male Reproductive, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0N80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Male Reproductive, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0P305","display":"Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0P30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0P705","display":"Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0P70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0P805","display":"Introduction of Other Antineoplastic into Female Reproductive, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0P80M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Female Reproductive, Via Natural or Artificial Opening Endoscopic"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Q305","display":"Introduction of Other Antineoplastic into Cranial Cavity and Brain, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Q30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Q705","display":"Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Q70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0R302","display":"Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0R303","display":"Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0R305","display":"Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0R30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0S302","display":"Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0S303","display":"Introduction of Low-dose Interleukin-2 into Epidural Space, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0S305","display":"Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0S30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0U305","display":"Introduction of Other Antineoplastic into Joints, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0U30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0V305","display":"Introduction of Other Antineoplastic into Bones, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0V30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0W305","display":"Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0W30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Y305","display":"Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Y30M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Y705","display":"Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E0Y70M","display":"Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening"}]}}